1. Home
  2. NAGE vs ATUS Comparison

NAGE vs ATUS Comparison

Compare NAGE & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • ATUS
  • Stock Information
  • Founded
  • NAGE 1999
  • ATUS 2015
  • Country
  • NAGE United States
  • ATUS United States
  • Employees
  • NAGE N/A
  • ATUS N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • ATUS Cable & Other Pay Television Services
  • Sector
  • NAGE Health Care
  • ATUS Telecommunications
  • Exchange
  • NAGE Nasdaq
  • ATUS Nasdaq
  • Market Cap
  • NAGE 861.0M
  • ATUS 1.0B
  • IPO Year
  • NAGE N/A
  • ATUS 2017
  • Fundamental
  • Price
  • NAGE $9.98
  • ATUS $2.39
  • Analyst Decision
  • NAGE Strong Buy
  • ATUS Buy
  • Analyst Count
  • NAGE 3
  • ATUS 5
  • Target Price
  • NAGE $17.00
  • ATUS $3.05
  • AVG Volume (30 Days)
  • NAGE 1.2M
  • ATUS 3.3M
  • Earning Date
  • NAGE 08-06-2025
  • ATUS 08-07-2025
  • Dividend Yield
  • NAGE N/A
  • ATUS N/A
  • EPS Growth
  • NAGE N/A
  • ATUS N/A
  • EPS
  • NAGE 0.22
  • ATUS N/A
  • Revenue
  • NAGE $116,303,000.00
  • ATUS $8,762,212,000.00
  • Revenue This Year
  • NAGE $26.44
  • ATUS N/A
  • Revenue Next Year
  • NAGE $20.06
  • ATUS N/A
  • P/E Ratio
  • NAGE $46.46
  • ATUS N/A
  • Revenue Growth
  • NAGE 35.90
  • ATUS N/A
  • 52 Week Low
  • NAGE $3.10
  • ATUS $1.61
  • 52 Week High
  • NAGE $14.69
  • ATUS $3.20
  • Technical
  • Relative Strength Index (RSI)
  • NAGE 48.56
  • ATUS 50.71
  • Support Level
  • NAGE $9.37
  • ATUS $2.15
  • Resistance Level
  • NAGE $10.45
  • ATUS $2.41
  • Average True Range (ATR)
  • NAGE 0.60
  • ATUS 0.13
  • MACD
  • NAGE 0.11
  • ATUS -0.00
  • Stochastic Oscillator
  • NAGE 43.29
  • ATUS 82.76

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About ATUS Altice USA Inc.

Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.

Share on Social Networks: